Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery (BFAKnee)

January 17, 2024 updated by: Mike O'Callaghan Military Hospital

Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial

The investigators propose to complete a randomized controlled trial to compare ear acupuncture at Cingulate gyrus, thalamus, omega 2, shen-men, and point zero on the right and left ear plus standard of care versus standard of care alone for symptomatic treatment of pain following ambulatory arthroscopic knee surgery. After the subject has been discharged, phone calls, emails or text messages will be made at 24 and 48 hours, 1 week and 1 month. These contacts will be used to assess the subject's pain level, ambulation status, doses of analgesics taken and time to return to full duty. At 1 week and 1 month, subjects will be asked the PIQ-6 Pain Impact Questionnaire.

Study Overview

Status

Completed

Conditions

Detailed Description

Subjects (DoD beneficiaries) that are 18 years or older with a scheduled ambulatory arthroscopic knee surgery will present for their pre-op appointment. At the time of check-in the subjects meeting the inclusion criteria, will be offered the opportunity to participate. Informed Consent and HIPAA Authorization will be obtained prior to any study-related procedures or any sedation being performed. The subject will be asked the screening questions for exclusion criteria (See attached instrument). The PI will have the AI or Study staffs recruit their patients to prevent any misconception of coercion. The subjects Armed Forces Health Longitudinal Technology Application (AHLTA) record including previous encounters, vital signs review, medication list, demographics and problems list will be reviewed by one of the investigators to confirm the inclusion/exclusion criteria have been met. The investigator will evaluate the subject and determine any further exclusion criteria based on exam. These subjects will then be randomized into two groups using a random number generator via block randomization by the Research Coordinator:

Group 1: Standard treatment alone Group 2: Standard treatment plus ear acupuncture

Subjects will be asked upon admittance to the PACU and the SDSU to answer the questions in the Data Collection Tool. Subjects will be given treatment while in the operating room and while under sedation according to their randomization group. The right and left ears will be cleansed with an alcohol swab prior to ear acupuncture. All subjects, regardless of study group, will get band aid to cover both ears. This is done to blind the orthopedic surgeon, the anesthesiologist and any nursing staff that comes in contact with the patient. Even though they are getting standard of care pain treatment, the investigators are blinding these individuals to remove any potential of bias when they are assessing a subject's pain. Subjects in both groups will be instructed to remove the band aids 24 hours after their surgery. After the subject has been discharged, phone calls, emails or text messages will be made at 24 and 48 hours, 1 week and 1 month. These contacts will be used to assess the subject's pain level, ambulation status, doses of analgesics taken and time to return to full duty. At 1 week and 1 month, subjects will be asked the PIQ-6 Pain Impact Questionnaire.

Subjects are getting the knee arthroscopy as part of standard of care in this study. It is standard of care to have military members return to to light-duty 2 weeks after knee arthroscopy and full-duty 6 weeks after knee arthroscopy. Should the subject return to duty with the acupuncture needles still in place, this will not affect their ability to perform their duties, however, to maintain compliance with AFI 36-2903, you may want to remove the needles or place a bandage over both ears to cover the ear acupuncture needles.

Ear acupuncture utilizes up to 10 needles. The ear Acupuncture points on the right ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The ear Acupuncture points on the left ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The subject will receive five needles intra-operatively on each ear.

Subject's participation in this study is completed after 1 month.

Patients in group 2 who are receiving ear Acupuncture will be instructed to have no heavy meals, excessive hot or cold foods, heavy exercise or intercourse and no alcohol for 24 hours. Ear Acupuncture needles will fall out on their own within about 6 days.

All investigators are trained in Battlefield Acupuncture and credentialed by the MOFH Credentials committee to perform Battlefield Acupuncture.

The investigators anticipate that the ear acupuncture will reduce the doses of analgesics needed to control pain, decrease time to discharge, reduce time to ambulation without assistance and improve return to duty time.

The standing orders for post-operative care pain control are attached. The risks associated with the use of ear acupuncture needles include: pain, bleeding, infection (very rare) and flare of signs and symptoms. In the event the acupuncture needles do not fall out within 6 days, patients will be instructed to come in and have them removed by one of the Investigators. In this study the investigators are using Sedatelec ASP Original Gold needles. These acupuncture needles are sterile, gold plated semi permanent ear acupuncture needles for single use.

If at any time during the study, the subject decides to withdraw from the study, they can come in and have the ear acupuncture needles removed by one of the Investigators. If patients are withdrawn from the study, they will have the option to either have the acupuncture needles removed by one of the investigators or allow them to fall out on their own.

Patients must agree to take precautions to prevent pregnancy during the initial phase (surgery) of this study. Pregnancy tests are routinely done as standard of care for all women prior to surgery. The only completely reliable methods of birth control are total abstinence or surgical removal of the uterus. Other methods, such as the use of condoms, a diaphragm or cervical cap, birth control pills, IUD, or sperm killing products are not totally effective in preventing pregnancy. Also, women who are breastfeeding at the time of surgery may not participate in this study.

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nevada
      • Nellis Air Force Base, Nevada, United States, 89191
        • Mike O'Callaghan Federal Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion:

  • Tricare beneficiaries receiving care at Nellis AFB.
  • Male and female subjects (DoD beneficiaries), 18 years or older scheduled for ambulatory unilateral arthroscopic knee surgery.
  • Unilateral arthroscopic knee surgery debridement.

Exclusion:

  • History of significant gastrointestinal bleed
  • Previous documented history of stage 2 kidney disease or worse
  • Pregnant or breastfeeding
  • History of gastric bypass surgery
  • Chronic oral steroids use
  • Absence of ear
  • Active cellulitis of ear
  • Ear anatomy precluding identification of acupuncture landmarks
  • Non-English speaking
  • Taking Coumadin or any Heparin-based anticoagulant
  • Use of Hearing Aids that preclude the insertion of ASP needles
  • Allergy to study medications
  • Inability to comply with study protocol
  • Arthroscopic knee surgery with ligamentous repair

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard treatment plus ear acupuncture
Ear acupuncture utilizes up to 10 needles. The ear Acupuncture points on the right ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The ear Acupuncture points on the left ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The subject will receive five needles intra-operatively on each ear.
Other Names:
  • Sedatelec ASP Original Gold needles
Placebo Comparator: standard
placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Participants With a Decrease in Pain Level
Time Frame: during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit) admissions, 24 and 48 hours, 1 week and 1 month
during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit) admissions, 24 and 48 hours, 1 week and 1 month
Ability to Ambulate Without Assistance
Time Frame: during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit), 24 and 48 hours, 1 week and 1 month
during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit), 24 and 48 hours, 1 week and 1 month
Number of Patients With Reduced Analgesic Use
Time Frame: during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit) admissions, 24 and 48 hours, 1 week and 1 month
during PACU (Post Anesthesia Care Unit) and SDSU (Same Day Surgical Unit) admissions, 24 and 48 hours, 1 week and 1 month

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of patients with reduced analgesic use
Time Frame: 7 months
7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Moss, M.D. Capt, Mike O'Callaghan Federal Hospital/Nellis AFB

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2011

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

October 4, 2011

First Submitted That Met QC Criteria

October 5, 2011

First Posted (Estimated)

October 6, 2011

Study Record Updates

Last Update Posted (Actual)

January 19, 2024

Last Update Submitted That Met QC Criteria

January 17, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • FWH20110169H

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Ear Acupuncture

3
Subscribe